10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
JOHNSON & JOHNSON | ||
Ticker: JNJ Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Jan 1, 2023 10-K (Filed: Feb 16, 2023) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Jan 1, 2023 | Jan 2, 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents (Notes 1 and 2) | $ 14,127 | 14,487 |
| Marketable securities (Notes 1 and 2) | 9,392 | 17,121 |
| Accounts receivable trade, less allowances for doubtful accounts $203 (2021, $230) | 16,160 | 15,283 |
| Inventories (Notes 1 and 3) | 12,483 | 10,387 |
| Prepaid expenses and other receivables | 3,132 | 3,701 |
| Total current assets | 55,294 | 60,979 |
| Property, plant and equipment, net (Notes 1 and 4) | 19,803 | 18,962 |
| Intangible assets, net (Notes 1 and 5) | 48,325 | 46,392 |
| Goodwill (Notes 1 and 5) | 45,231 | 35,246 |
| Deferred taxes on income (Note 8) | 9,123 | 10,223 |
| Other assets | 9,602 | 10,216 |
| Total assets | 187,378 | 182,018 |
| Liabilities and Shareholders Equity | ||
| Current liabilities | ||
| Loans and notes payable (Note 7) | 12,771 | 3,766 |
| Accounts payable | 11,703 | 11,055 |
| Accrued liabilities | 11,456 | 13,612 |
| Accrued rebates, returns and promotions | 14,417 | 12,095 |
| Accrued compensation and employee related obligations | 3,328 | 3,586 |
| Accrued taxes on income (Note 8) | 2,127 | 1,112 |
| Total current liabilities | 55,802 | 45,226 |
| Long-term debt (Note 7) | 26,888 | 29,985 |
| Deferred taxes on income (Note 8) | 6,374 | 7,487 |
| Employee related obligations (Notes 9 and 10) | 6,767 | 8,898 |
| Long-term taxes payable (Note 1) | 4,306 | 5,713 |
| Other liabilities | 10,437 | 10,686 |
| Total liabilities | 110,574 | 107,995 |
| Commitments and Contingencies (Note 19) | ||
| Shareholders equity | ||
| Preferred stock without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
| Common stock par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
| Accumulated other comprehensive income (loss) (Note 13) | (12,967) | (13,058) |
| Retained earnings | 128,345 | 123,060 |
| Stockholders' Equity before Treasury Stock | 118,498 | 113,122 |
| Less: common stock held in treasury, at cost (Note 12) (506,246,000 shares and 490,878,000 shares) | 41,694 | 39,099 |
| Total shareholders equity | 76,804 | 74,023 |
| Total liabilities and shareholders equity | 187,378 | 182,018 |
| External Links | |
| JOHNSON & JOHNSON (JNJ) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |